TITLE

PENTRIUM THERAPY IN ANGINA PECTORIS

AUTHOR(S)
Dougherty, Edward S.
PUB. DATE
February 1965
SOURCE
Angiology;Feb1965, Vol. 16 Issue 2, p57
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
1. Clinical evaluation of Pentrium, a new Librium/PETN combination, was conducted by means of a single-blind comparative study in 100 women patients with angina pectoris. 2. Employing comparable dosages, four agents�the patients' previous medication (a vasodilator), Librium alone, a placebo, and the test drug, Pentrium, rotated over four consecutive one-month periods, were compared as to their efficacy in lessening anginal attacks. The average daily nitroglycerin requirements (ADNR) of each subject served as the standard measure. 3. Results computed in comparative percentages showed that 76 patients required from 11 to 91 per cent less nitroglycerin during the month of Pentrium therapy than during their previous baseline (control) period on vasodilator, alone, whereas, 19 patients had increased ADNR with the test drug. Three patients showed insignificant increases or decreases (+ or -10 per cent) while two showed no change. 4. The ADNR per patient measured during Librium therapy, alone, versus the vasodilator, alone, showed comparable amounts of 1.7 and 1.5 tablets, respectively, while during placebo administration, all 100 patients' ADNR increased from over three to over five tablets per patient. The daily requirements of the group averaged less than one tablet (0.8) during Pentrium treatment. 5. The overall reduction in nitroglycerin requirements during Pentrium therapy, as compared with requirements during the vasodilator therapy alone, was found to be significant at the 0.001 level, on the basis of a nonparametric technique, the sign test.
ACCESSION #
16378076

 

Related Articles

  • Heart Rate Variability Analysis at Coronary Artery Disease and Angina Pectoris. Mironova, Tatyana; Mironov, Vladimir; Antufiev, Vladimir; Safronova, Eleonora; Mironov, Michael; Davydova, Evgenia // Recent Patents on Cardiovascular Drug Discovery;Jan2009, Vol. 4 Issue 1, p45 

    The purpose of this study was to present results of special examination and prospective observation of patients with coronary artery disease (CAD) and angina pectoris (AP) in practical cardiology. Except standard cardiological methods, we used high-resolution rhythmocardiography and...

  • New Report of Severe Coronary Artery Disease in an Eighteen-Year-Old Girl with Pseudoxanthoma Elasticum. K�vorkian, Jean-Philippe; Masquet, Christiane; Kural-M�nasch�, Suzanne; Le Dref, Olivier; Beaufils, Philippe // Angiology;Aug1997, Vol. 48 Issue 8, p735 

    An eighteen-year-old woman with pseudoxanthoma elasticum (PXE) suffered from mild angina pectoris over a ten-year period. Severe triple-vessel disease with mild left ventricular dysfunction was demonstrated on angiography. No revascularization was feasible. Despite a reported high frequency of...

  • A CLINICAL STUDY OF A MULTIFACETED TREATMENT IN CORONARY INSUFFICIENCY. Eisfelder, Henry W. // Angiology;Mar1961, Vol. 12 Issue 3, p109 

    Sixty-eight subjects with coronary insufficiency, 23 postcoronary patients and 45 with developing arteriosclerotic heart disease, were placed on a program consisting of three elements: emergency medication (nitroglycerin), a long-acting protective agent (trolnitrate phosphate), and reassurance...

  • Sustac. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p723 

    An encyclopedia entry for "Sustac" is presented. It is the brand name for glyceryl trinitrate, a drug used to prevent attacks of angina pectoris.

  • Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention. Bonello, Laurent; Sbragia, Pascal; Amabile, Nicolas; Com, Olivier; Pierre, Sandrine V.; Levy, Samuel; Paganelli, Franck // Heart;Jun2007, Vol. 93 Issue 6, p703 

    Objective: To evaluate the effect of pre-procedural acute oral administration of trimetazidine (TMZ) on percutaneous coronary intervention (PCI)-induced myocardial injury. Design: Single-centre, prospective, randomised evaluation study. Setting: Patients with stable angina pectoris and...

  • MONOAMINE OXIDASE INHIBITORS AND VASCULAR DISEASE.  // Angiology;Feb1960 Part 2, Vol. 11 Issue 1, p53 

    Examines the pharmacology of monoamine oxidase inhibitors. Importance of amines in the functions of the body; Effects of the inhibitors on angina pectoris and the anginal syndrome; Use of the inhibitors in the treatment of vascular diseases.

  • Coronary Artery Aneurysms. Dağalp, Zehra; Pamir, Gülgün; Ahmet Alpman; Ömürlü, Kenan; Erol, Çetin; Oral, Derviş // Angiology;Feb1996, Vol. 47 Issue 2, p197 

    Two patients who had angiographically proven coronary anery aneurysms are presented. The clinical pictures of these patients were similar to that of patients with atherosclerotic coronary artery disease. Both had severe angina pectoris, and the second patient (case 2) had had myocardial...

  • ANGINA PECTORIS. Shapiro, Shepard // Angiology;Feb1961, Vol. 12 Issue 2, p53 

    Angina pectoris occurs when the oxygen supply to the myocardium falls below the physiologic requirement of the moment. This anoxia is reversible and when the oxygen supply becomes adequate the angina attack subsides. These attacks can be prevented or controlled by coronary vasodilator drugs. The...

  • Medical Management of Angina Pectoris. Burch, G. E. // Angiology;Oct1979, Vol. 30 Issue 10, p667 

    Discusses the treatment or medical management of angina pectoris. Aspects of medical management for effective care of patients with angina pectoris; Need for the application of the existing knowledge to the best interest of patients suffering from various syndromes of ischemic heart disease;...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics